메뉴 건너뛰기




Volumn 99, Issue 8, 2001, Pages 449-450

Topiramate: A new safe and effective antiepileptic

Author keywords

Antiepileptic; Refractory partial epilepsy; Topiramate

Indexed keywords

CARBAMAZEPINE; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

EID: 0035697021     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (6)

References (7)
  • 1
    • 10544255353 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
    • Sharief M, Viteri C, Ben-Menachem E - Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996; 25: 217-24.
    • (1996) Epilepsy Res , vol.25 , pp. 217-224
    • Sharief, M.1    Viteri, C.2    Ben-Menachem, E.3
  • 2
    • 0029922566 scopus 로고    scopus 로고
    • Topiramate placebo-controlled dose-ranging trial in refraciory partial epilepsy using 200-, 400-, and 600-mg daily dosages
    • Faught E, Wilder BJ, Ramsay RE, Reife RA, Kramer LD, Pledger GW, et al - Topiramate placebo-controlled dose-ranging trial in refraciory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996; 46: 1684-90.
    • (1996) Neurology , vol.46 , pp. 1684-1690
    • Faught, E.1    Wilder, B.J.2    Ramsay, R.E.3    Reife, R.A.4    Kramer, L.D.5    Pledger, G.W.6
  • 3
    • 0029884747 scopus 로고    scopus 로고
    • Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800- And 1,000-mg daily dosages: Topiramate YE Study Group
    • Privitera M, Fincham R, Penry J, Reife R, Kramer L, Pledger G, et al - Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800- and 1,000-mg daily dosages: Topiramate YE Study Group. Neurology 1996; 46: 1678-83.
    • (1996) Neurology , vol.46 , pp. 1678-1683
    • Privitera, M.1    Fincham, R.2    Penry, J.3    Reife, R.4    Kramer, L.5    Pledger, G.6
  • 4
    • 9444251680 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy
    • Tassinari CA, Michelucci, R, Chauvel P, Chodkiewicz J, Shorvon S, Henriksen O, et al - Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia. 1996; 37: 763-8.
    • (1996) Epilepsia. , vol.37 , pp. 763-768
    • Tassinari, C.A.1    Michelucci, R.2    Chauvel, P.3    Chodkiewicz, J.4    Shorvon, S.5    Henriksen, O.6
  • 5
    • 0043181917 scopus 로고    scopus 로고
    • Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures
    • Ben-Menachem E, Henriksen O, Dam M, Mikkelsen M. Schmidt D, Reid S, et al - Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia.1996; 37: 539-43.
    • (1996) Epilepsia. , vol.37 , pp. 539-543
    • Ben-Menachem, E.1    Henriksen, O.2    Dam, M.3    Mikkelsen, M.4    Schmidt, D.5    Reid, S.6
  • 6
    • 0344949538 scopus 로고
    • Topiramate: US trial experience in partial epilepsy
    • Oslo. Norway
    • Faught RE - Topiramate: US trial experience in partial epilepsy. 20th International Epilepsy Congress. Oslo. Norway, 1993.
    • (1993) 20th International Epilepsy Congress
    • Faught, R.E.1
  • 7
    • 0029954487 scopus 로고    scopus 로고
    • Safety of topiramate: Adverse events and relationships to dosing
    • Shorvon SD - Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996; 37: S18-S22.
    • (1996) Epilepsia , vol.37
    • Shorvon, S.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.